sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease
Abstract
In an effort to gain deeper insight into the molecular processes underlying neurodegeneration in Parkinson's disease, we performed gene expression profiling at several early time points after MPTP-injection into old (1-year) mice. We used a PCR-based gene expression profiling method, digital expression pattern display (DEPD), a method of very high sensitivity and reproducibility, which displays almost all transcripts of a tissue. To identify cell death-associated genes, we defined clusters of differentially expressed transcripts with expression behaviour that correlated with the temporal profile of cell death progression and characterized one of these cell death clusters further. We selected one of the strongest regulated genes, the serum and glucocorticoid-regulated kinase 1 (sgk1), and validated its differential expression by Northern blot analysis, semiquantitative PCR and in situ hybridization. Up-regulation of sgk1 (i) coincides with the onset of dopaminergic cell death in both the 8-week acute and 1-year subacute MPTP models, (ii) spans the entire brain, (iii) is attenuated by the l-deprenyl-mediated inhibition of the MPTP conversion to its active metabolite MPP+ and (iv) is not induced by dehydration. This study demonstrated that the combination of the DEPD technology, clustering analysis and a detailed histopathology is a useful tool for elucidating molecular pathways in neurodegenerative diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In brains of MPTP-induced PD mice, increased SGK1 transcriptome levels coincide with onset of dopaminergic cell death.
“early PCR-based gene expression profiling methods, such as the Digital Expression Pattern Display, have identified that in the brains of MPTP-induced PD mice, increased SGK1 transcriptome levels coincide with the onset of dopaminergic cell death”
From Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain (2024) · cites this paper as Stichel et al., 2005
Cites
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
Lang, F., Böhmer, C., Palmada, M., Seebohm, G., Strutz-Seebohm, N., & Vallon, V. (2006) · Physiological Reviews · doi:10.1152/physrev.00050.2005 · Cited by 689 · see citing works
Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain
Howard, P. G., Zou, P., Zhang, Y., Huang, F., Tesic, V., Wu, C. Y.-C., & Lee, R. H.-C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114973 · Cited by 13 · see citing works
Computational insights into the active structure of SGK1 and its implication for ligand design
Akhoon, B. A., Gandhi, N. S., & Pandey, R. (2019) · Biochimie · doi:10.1016/j.biochi.2019.07.007 · Cited by 9 · see citing works
- Authors
- Stichel, C. C., Schoenebeck, B., Foguet, M., Siebertz, B., Bader, V., Zhu, X. R., & Lübbert, H.
- Affiliations
- Biofrontera (Germany) (DE)
- Ruhr University Bochum (DE)
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2005-01
- Volume
- 21
- Issue
- 2
- Pages
- 301-316
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2035752371
- Cited by
- 43
- References
- 1
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 1 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 2 · 2015: 3 · 2013: 2 · 2012: 1
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- SGK1, Parkinson's disease, MPTP, dopaminergic neuron loss, neurodegeneration, gene expression profiling, selegiline, MPP+, aged mice
- MeSH terms
- Serum-Glucocorticoid Regulated Kinases, Age Factors, Animals, Antiparkinson Agents, Astrocytes, Brain, Disease Models, Animal, Drug Interactions, Food Deprivation, Gene Expression Regulation, Glial Fibrillary Acidic Protein, Neurons, Nuclear Proteins, RNA, Messenger, Selegiline, Time Factors, Tyrosine 3-Monooxygenase, Water Deprivation, Blotting, Northern, Gene Expression, Cluster Analysis, Cell Death, Protein Serine-Threonine Kinases, In Situ Hybridization, Immediate-Early Proteins, Reverse Transcriptase Polymerase Chain Reaction, Parkinsonian Disorders, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review